128 related articles for article (PubMed ID: 38299265)
1. Red fluorescent BODIPY-based nanoparticles for targeted cancer imaging-guided photodynamic therapy.
Kim C; Mai DK; Kim WJ; Badon IW; Jo J; Kang D; Kim SJ; Kim HJ; Yang J
Biomater Sci; 2024 Mar; 12(6):1536-1548. PubMed ID: 38299265
[TBL] [Abstract][Full Text] [Related]
2. 2-Pyridone-functionalized Aza-BODIPY photosensitizer for imaging-guided sustainable phototherapy.
Xiao W; Wang P; Ou C; Huang X; Tang Y; Wu M; Si W; Shao J; Huang W; Dong X
Biomaterials; 2018 Nov; 183():1-9. PubMed ID: 30142531
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic Therapy with Targeted Release of Boron-Dipyrromethene Dye from Cobalt(III) Prodrugs in Red Light.
Jana A; Sahoo S; Paul S; Sahoo S; Jayabaskaran C; Chakravarty AR
Inorg Chem; 2024 Apr; 63(15):6822-6835. PubMed ID: 38560761
[TBL] [Abstract][Full Text] [Related]
4. pH-Responsive PEG-Doxorubicin-Encapsulated Aza-BODIPY Nanotheranostic Agent for Imaging-Guided Synergistic Cancer Therapy.
Chen D; Tang Q; Zou J; Yang X; Huang W; Zhang Q; Shao J; Dong X
Adv Healthc Mater; 2018 Apr; 7(7):e1701272. PubMed ID: 29334184
[TBL] [Abstract][Full Text] [Related]
5. Formylation as a Chemical Tool to Modulate the Performance of Photosensitizers Based on Boron Dipyrromethene Dimers.
Díaz-Norambuena C; Avellanal-Zaballa E; Prieto-Castañeda A; Bañuelos J; de la Moya S; Agarrabeitia AR; Ortiz MJ
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511596
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Nanoparticles Covalently Bound with BODIPY for Their Photodynamic Therapy Applicability.
Malacarne MC; Caruso E; Gariboldi MB; Marras E; Della Bitta G; Santoro O; Simm A; Li R; Ferguson CTJ
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542161
[TBL] [Abstract][Full Text] [Related]
7. Molecular Design of Highly Efficient Heavy-Atom-Free Triplet BODIPY Derivatives for Photodynamic Therapy and Bioimaging.
Nguyen VN; Yim Y; Kim S; Ryu B; Swamy KMK; Kim G; Kwon N; Kim CY; Park S; Yoon J
Angew Chem Int Ed Engl; 2020 Jun; 59(23):8957-8962. PubMed ID: 32125064
[TBL] [Abstract][Full Text] [Related]
8. Halogenated BODIPY photosensitizers: Photophysical processes for generation of excited triplet state, excited singlet state and singlet oxygen.
Hu W; Zhang R; Zhang XF; Liu J; Luo L
Spectrochim Acta A Mol Biomol Spectrosc; 2022 May; 272():120965. PubMed ID: 35131619
[TBL] [Abstract][Full Text] [Related]
9. Lysosome directed red light photodynamic therapy using glycosylated iron-(III) conjugates of boron-dipyrromethene.
Sahoo S; Pathak S; Kumar A; Nandi D; Chakravarty AR
J Inorg Biochem; 2023 Jul; 244():112226. PubMed ID: 37105008
[TBL] [Abstract][Full Text] [Related]
10. Triphenylphosphonium-functionalized dimeric BODIPY-based nanoparticles for mitochondria-targeting photodynamic therapy.
Kim C; Mai DK; Lee J; Jo J; Kim S; Badon IW; Lim JM; Kim HJ; Yang J
Nanoscale; 2024 May; 16(19):9462-9475. PubMed ID: 38639449
[TBL] [Abstract][Full Text] [Related]
11. Boron Dipyrromethene-Based Phototheranostics for Near Infrared Fluorescent and Photoacoustic Imaging-Guided Synchronous Photodynamic and Photothermal Therapy of Cancer.
Xing X; Yang K; Li B; Tan S; Yi J; Li X; Pang E; Wang B; Song X; Lan M
J Phys Chem Lett; 2022 Sep; 13(34):7939-7946. PubMed ID: 35980815
[TBL] [Abstract][Full Text] [Related]
12. BODIPY-fused uracil: synthesis, photophysical properties, and applications.
Nagpal A; Tyagi N; Neelakandan PP
Photochem Photobiol Sci; 2024 Feb; 23(2):365-376. PubMed ID: 38227134
[TBL] [Abstract][Full Text] [Related]
13. Ubiquinone-BODIPY nanoparticles for tumor redox-responsive fluorescence imaging and photodynamic activity.
Hwang B; Kim TI; Kim H; Jeon S; Choi Y; Kim Y
J Mater Chem B; 2021 Jan; 9(3):824-831. PubMed ID: 33338098
[TBL] [Abstract][Full Text] [Related]
14. Singlet Oxygen-Responsive Polymeric Nanomedicine for Light-Controlled Drug Release and Image-Guided Photodynamic-Chemo Combination Therapy.
Yang DC; Wang S; Weng XL; Zhang HX; Liu JY; Lin Z
ACS Appl Mater Interfaces; 2021 Jul; 13(29):33905-33914. PubMed ID: 34278780
[TBL] [Abstract][Full Text] [Related]
15. BODIPY nanoparticles functionalized with lactose for cancer-targeted and fluorescence imaging-guided photodynamic therapy.
Mai DK; Kim C; Lee J; Vales TP; Badon IW; De K; Cho S; Yang J; Kim HJ
Sci Rep; 2022 Feb; 12(1):2541. PubMed ID: 35169149
[TBL] [Abstract][Full Text] [Related]
16. BODIPY-based monofunctional Pt (II) complexes for specific photocytotoxicity against cancer cells.
Qi F; Yuan H; Chen Y; Guo Y; Zhang S; Liu Z; He W; Guo Z
J Inorg Biochem; 2021 May; 218():111394. PubMed ID: 33647541
[TBL] [Abstract][Full Text] [Related]
17. pH-Triggered Polypeptides Nanoparticles for Efficient BODIPY Imaging-Guided Near Infrared Photodynamic Therapy.
Liu L; Fu L; Jing T; Ruan Z; Yan L
ACS Appl Mater Interfaces; 2016 Apr; 8(14):8980-90. PubMed ID: 27020730
[TBL] [Abstract][Full Text] [Related]
18. A Versatile Theranostic Nanoemulsion for Architecture-Dependent Multimodal Imaging and Dually Augmented Photodynamic Therapy.
Zhang Y; Bo S; Feng T; Qin X; Wan Y; Jiang S; Li C; Lin J; Wang T; Zhou X; Jiang ZX; Huang P
Adv Mater; 2019 May; 31(21):e1806444. PubMed ID: 30907469
[TBL] [Abstract][Full Text] [Related]
19. Self-quenching synthesis of coordination polymer pre-drug nanoparticles for selective photodynamic therapy.
Song Y; Li Y; Zhang Y; Wang L; Xie Z
J Mater Chem B; 2019 Dec; 7(48):7776-7782. PubMed ID: 31754677
[TBL] [Abstract][Full Text] [Related]
20. Specific light-up pullulan-based nanoparticles with reduction-triggered emission and activatable photoactivity for the imaging and photodynamic killing of cancer cells.
Xia J; Zhang L; Qian M; Bao Y; Wang J; Li Y
J Colloid Interface Sci; 2017 Jul; 498():170-181. PubMed ID: 28324723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]